Kinases in motion: impact of protein and small molecule interactions on kinase conformations

Author:

Kugler Valentina12ORCID,Schwaighofer Selina12ORCID,Feichtner Andreas12,Enzler Florian3,Fleischmann Jakob12,Strich Sophie12,Schwarz Sarah2,Wilson Rebecca4,Tschaikner Philipp25,Troppmair Jakob3,Sexl Veronika6,Meier Pascal4,Kaserer Teresa7ORCID,Stefan Eduard125

Affiliation:

1. Institute for Molecular Biology and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck

2. Tyrolean Cancer Research Institute (TKFI)

3. Daniel Swarovski Research Laboratory, Department of Visceral, Transplant and Thoracic Surgery, Medical University of Innsbruck

4. The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research

5. KinCon biolabs GmbH

6. University of Innsbruck

7. Institute of Pharmacy/Pharmaceutical Chemistry and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck

Abstract

Protein kinases act as central molecular switches in the control of cellular functions. Alterations in the regulation and function of protein kinases may provoke diseases including cancer. In this study we investigate the conformational states of such disease-associated kinases using the high sensitivity of the Kinase Conformation (KinCon)-reporter system. We first track BRAF-kinase activity conformation changes upon melanoma drug binding. Second, we also use the KinCon reporter technology to examine the impact of regulatory protein interactions on LKB1-kinase tumor suppressor functions. Third, we explore the conformational dynamics of RIP-kinases in response to TNF-pathway activation and small molecule interactions. Finally, we show that CDK4/6 interactions with regulatory proteins alter conformations which remain unaffected in the presence of clinically applied inhibitors. Apart from its predictive value, the KinCon technology helps to identify cellular factors that impact drug efficacies. The understanding of the structural dynamics of full-length protein kinases when interacting with small molecule inhibitors or regulatory proteins is crucial for designing more effective therapeutic strategies.

Publisher

eLife Sciences Publications, Ltd

Reference150 articles.

1. The evolution of non-small cell lung cancer metastases in TRACERx;Nature,2023

2. Mechanisms of sensitivity and resistance to CDK4/6 inhibition;Cancer cell,2020

3. Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors;Journal of Biological Chemistry,2022

4. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade;Recent progress in hormone research,2001

5. Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD;The EMBO journal,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3